Literature DB >> 23626655

Latest trends in drugs of abuse - HIV infection and neuroAIDS.

Sneham Tiwari1, Madhavan Pn Nair, Shailendra K Saxena.   

Abstract

Drug abuse and co-occurring infections are associated with significant morbidity and mortality. In particular, HIV infection is associated with serious neurological complications, including neuroAIDS. Therefore, on 13-15 September 2012, the OMICS Group (USA) and Shailendra K Saxena (Centre for Cellular and Molecular Biology, India) hosted a symposium titled: 'Drugs of Abuse - HIV Infection and NeuroAIDS: A Global Perspective' that was cochaired by Jag H Khalsa and Jeymohan Joseph of the NIH, MD, USA, at the 3rd World Congress on Biotechnology, in Hyderabad, India. Renowned scientists from India and the USA highlighted a number of issues, including the epidemiology, causes and underlying pathophysiological mechanisms of neuroAIDS, impact on health, and designing new treatment modalities (e.g., nanotherapeutics) for the treatment of neurological disorders.

Entities:  

Keywords:  HIV; alcohol; cocaine; drug abuse; methamphetamine; morphine; neuroAIDS; tobacco

Year:  2013        PMID: 23626655      PMCID: PMC3634594          DOI: 10.2217/fvl.12.134

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  27 in total

Review 1.  Cannabinoid neuroimmune modulation of SIV disease.

Authors:  Patricia E Molina; Angela Amedee; Nicole J LeCapitaine; Jovanny Zabaleta; Mahesh Mohan; Peter Winsauer; Curtis Vande Stouwe
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-10       Impact factor: 4.147

2.  Activation and desensitization of Fos immunoreactivity in the rat brain following ethanol administration.

Authors:  S L Chang; N A Patel; A A Romero
Journal:  Brain Res       Date:  1995-05-08       Impact factor: 3.252

3.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Authors:  Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

Review 4.  Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia.

Authors:  Avi Nath
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

5.  Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users.

Authors:  L Chang; T Ernst; T Strickland; C M Mehringer
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

6.  Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability.

Authors:  Honghong Yao; Ming Duan; Shilpa Buch
Journal:  Blood       Date:  2010-12-08       Impact factor: 22.113

7.  Cocaine hijacks σ1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS.

Authors:  Honghong Yao; Keejun Kim; Ming Duan; Teruo Hayashi; Minglei Guo; Susan Morgello; Alexander Prat; John Wang; Tsung-Ping Su; Shilpa Buch
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

8.  Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS.

Authors:  Thangavel Samikkannu; Kurapati V K Rao; Nimisha Gandhi; Shailendra K Saxena; Madhavan P N Nair
Journal:  J Neurovirol       Date:  2010-07       Impact factor: 2.643

Review 9.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

10.  Chronic alcohol accentuates simian acquired immunodeficiency syndrome-associated wasting.

Authors:  Patricia E Molina; Charles H Lang; Margaret McNurlan; Gregory J Bagby; Steve Nelson
Journal:  Alcohol Clin Exp Res       Date:  2007-11-20       Impact factor: 3.455

View more
  7 in total

1.  Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels.

Authors:  T Celeste Napier; Lihua Chen; Fatah Kashanchi; Xiu-Ti Hu
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-25       Impact factor: 4.147

Review 2.  HIV-associated cellular senescence: A contributor to accelerated aging.

Authors:  Justin Cohen; Claudio Torres
Journal:  Ageing Res Rev       Date:  2016-12-23       Impact factor: 10.895

3.  Methamphetamine compromises gap junctional communication in astrocytes and neurons.

Authors:  Paul Castellano; Chisom Nwagbo; Luis R Martinez; Eliseo A Eugenin
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

4.  18O proteomics reveal increased human apolipoprotein CIII in Hispanic HIV-1+ women with HAART that use cocaine.

Authors:  Frances Zenón; Inmaculada Jorge; Ailed Cruz; Erick Suárez; Annabell C Segarra; Jesús Vázquez; Loyda M Meléndez; Horacio Serrano
Journal:  Proteomics Clin Appl       Date:  2015-11-19       Impact factor: 3.494

5.  Modulation of OPRM1 Alternative Splicing by Morphine and HIV-1 Nef.

Authors:  Martina Donadoni; Wenfei Huang; Shadan S Yarandi; Tricia H Burdo; Sulie L Chang; Ilker K Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2021-08-21       Impact factor: 4.147

6.  Cocaine Self-Administration Influences Central Nervous System Immune Responses in Male HIV-1 Transgenic Rats.

Authors:  Chiomah Ezeomah; Chanida Fongsaran; Amanda L Persons; T Celeste Napier; Irma E Cisneros
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

Review 7.  Interactive effects of cocaine on HIV infection: implication in HIV-associated neurocognitive disorder and neuroAIDS.

Authors:  Santosh Dahal; Sai V P Chitti; Madhavan P N Nair; Shailendra K Saxena
Journal:  Front Microbiol       Date:  2015-09-08       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.